TITLE

Cardiovascular highlights from non-cardiology journals

AUTHOR(S)
Lindsay, Alistair C.; Contractor, Hussain
PUB. DATE
February 2011
SOURCE
Heart;Feb2011, Vol. 97 Issue 4, p338
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article summarizes cardiovascular studies published in non-cardiology journals as of February 2011. The Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) discovered that further lowering of low-density lipoprotein (LDL)-cholesterol is safe. Another research stressed the role of population characteristics in variations in coronary heart disease (CHD) mortality across England. One study concluded that eplerenone is more effective than placebo in patients with systolic heart failure and mild symptoms.
ACCESSION #
60961442

 

Related Articles

  • Aortic valve involvement and premature coronary artery disease in Heterozygous Familial Hypercholesterolemia. Şimşek, Hakkı; Tuncer, Mustafa; Şahin, Musa; Gümrükçüoğlu, Hasan Ali; Eryonucu, Beyhan // Journal of Clinical & Experimental Investigations / Klinik ve De;2011, Vol. 2 Issue 3, p308 

    Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by an elevation of LDL cholesterol concentration in plasma leading to deposition of excess LDL-derived cholesterol in tendons, skin and arteries. We studied a 34 year old woman who applied to dermatology...

  • Patients with low LDL still demonstrated CAD progression.  // Cardiology Today;Jul2010, Vol. 13 Issue 7, p30 

    The article discusses research on the link between low density lipoproteins (LDL) level and coronary artery disease progression, by O. Bayturan and colleagues, published in the 2010 issue of the "Journal of the American College of Cardiology."

  • Quality improvement initiatives required to reduce repeat lipid testing.  // Endocrine Today;Aug2013, Vol. 12 Issue 8, p1 

    The article reports on a study which found that one-third of patients with coronary heart disease who reached target low-density lipoprotein (LDL) levels underwent repeat lipid panels, suggesting that quality improvement initiatives are required to reduce repeat lipid testing.

  • Conventional and Advanced Lipid Parameters in Premature Coronary Artery Disease Patients in India. BANSAL, SANJIV KUMAR; AGARWAL, SARITA; DAGA, MRIDUL KUMAR // Journal of Clinical & Diagnostic Research;Nov2015, Vol. 9 Issue 11, p7 

    Background: Coronary artery disease (CAD) is the leading cause of death worldwide and has assumed alarming proportions in India with gradual increase in its incidence and prevalence over the last decade. India is in the middle of epidemic of coronary artery disease which is leading cause of...

  • Association of Fibronectin, Leptin and LDL-Oxide Serum Levels With Coronary Artery Disease in Non-smoker and Non-diabetic Patients. Yaghoubi, Ali Reza; Kargar, Farank; Khaki-Khatibi, Fatemeh // Crescent Journal of Medical & Biological Sciences;Jan2016, Vol. 3 Issue 1, p23 

    Objective: Coronary artery disease (CAD) is a leading cause of death of women and men worldwide. Endothelial dysfunction, smoker, diabetic, cell adhesion and oxidative stress may be considered as novel risk factors of CAD. These materials are cooperative events involved in atherosclerosis...

  • Low-Density Lipoprotein Cholesterol in Patients with Stable Coronary Heart Disease – Is It Time to Shift Our Goals? Pitt, Bertram // New England Journal of Medicine;4/7/2005, Vol. 352 Issue 14, p1483 

    The article focuses on the effectiveness of statins in the treatment of stable coronary heart disease (CHD). Secondary prevention trials have shown that statins reduce the clinical consequences of atherosclerosis, including death from cardiovascular causes and heart failure. Current guidelines...

  • Homocysteine in Angiographically Proven Coronary Disease. Halilovic, Enes; Kabil, Emir; Ljuca, Farid; Nuhbegovic, Sabina // Medicinski Arhiv;2009, Vol. 63 Issue 5, p256 

    The research included 200 subjects, of which 150 had angiographically proven coronary disease with the coronary artery stenosis of 50% or more, and 50 subjects who did not have angiographically proven coronary disease. Patients were chosen randomly out of approximately 1000 patients who...

  • Aggressive lipid-lowering may obviate need for angioplasty in stable CHD.  // Modern Medicine;Dec98, Vol. 66 Issue 12, p47 

    Suggests that patients with stable coronary heart disease who are candidates for angioplasty may be better off with aggressive medical therapy for lowering their low density lipoproteins (LDL) cholesterol. Clinical trial conducted by Doctor Bertram Pitt; Explanations from Pitt; Implication of...

  • Association between Serum Ferritin and Circulating Oxidized Low-density Lipoprotein Levels in Patients with Coronary Artery Disease. Khalili, Ahmadali; Ghorbanihaghjo, Amir; Rashtchizadeh, Nadereh; Gaffari, Samad // Journal of Cardiovascular & Thoracic Research;2012, Vol. 4 Issue 1, p1 

    Introduction: Oxidation of low-density lipoprotein (LDL) is believed to be a key factor in the development of atherosclerosis. Oxidative modification of LDL is associated with increased uptake of these particles by the macrophage receptors located in the arterial wall which in turns would lead...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics